Navigation Links
PreViser and Oral Health Innovations Ltd Form UK Partnership to Provide Oral Health Scoring and Risk Analysis
Date:5/20/2008

MOUNT VERNON, Wash., May 20 /PRNewswire/ -- PreViser Corporation (http://www.previser.com), a Washington State-based provider of patented oral disease and risk assessment technology to the dental profession, announced today the finalization of a licensing agreement with Oral Health Innovations (OHI) Ltd (http://www.previser.co.uk) of Birmingham, England to market PreViser technology to dentists within the United Kingdom and the Republic of Ireland.

OHI Ltd is a joint venture with the University of Birmingham. Following a successful pilot, OHI will launch PreViser at a Denplan-sponsored seminar for its Excel accredited practitioners in June 2008. Discussions are also underway with a number of Primary Care Trusts on how the technology can be used as a best practice tool within National Health Service (NHS) dentistry.

Iain Chapple, Professor of Periodontology and Consultant in Restorative Dentistry, who runs an NHS referral center serving approximately six million patients, acts as adviser to OHI Ltd. Prof. Chapple commented, "PreViser is unique in its web-based approach to risk and disease scoring and has a scientific evidence base behind its efficacy. However, one of its biggest benefits is the immediate and personalized biofeedback it offers to patients. We all know that successful periodontal therapy is founded on patient education and compliance with home care regimes. PreViser is a most innovative tool that motivates patients to take personal responsibility for their own oral health.

"In addition to the obvious patient and practitioner benefits, PreViser allows oral healthcare funders to focus their resources towards those that need it most and provides a platform from which to deliver truly preventative oral care in a cost effective manner.

"As a teacher, it is exciting to be able to utilize the system, which is provided fr
'/>"/>

SOURCE PreViser Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , ... August 27, 2015 , ... ... Medicine, recently presented new data on the relationship of genetics and hypertension at ... Congress on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts ...
(Date:8/26/2015)... VANCOUVER , Aug. 26, 2015 /PRNewswire/ - iCo ... ICOTF), today reported financial results for the quarter ... are expressed in Canadian dollars and presented under ... continue pre-clinical activities with respect to our Oral ... of a contract manufacturer," said Andrew Rae ...
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, ... the development and manufacture of highly valued cardiac markers used in early detection ... expertise with protein chemistry has led to the development and commercialization of important ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
Breaking Biology Technology:Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
... CAMBRIDGE, Mass., Jan. 12 Cequent Pharmaceuticals, a pioneer ... treatments to prevent and treat human disease, announced that ... officer. Mr. Hibben comes to Cequent from Coley Pharmaceutical ... business development and alliance management and played a key ...
... Human Genome Sciences, Inc. (Nasdaq: HGSI ... Annual JPMorgan Healthcare Conference will be webcast and may ... )A member of Human Genome Sciences, senior management ... Wednesday, January 14, 2009 at 7:30 am Pacific Time ...
... to Enable Stockholders to Determine Fate of Company,s ... Avigen Stockholders Extraordinary Risk/Reward OpportunitySAN FRANCISCO, Jan. 9 ... affiliates ("BVF") today announced that it has requested ... ("Avigen") (Nasdaq: AVGN ) call a ...
Cached Biology Technology:Cequent Names Ted Hibben Chief Business Officer 2Cequent Names Ted Hibben Chief Business Officer 3Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 2Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 3Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 4Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 5
(Date:8/5/2015)... , Aug. 5, 2015 The biosensors ... growth in applications, penetration into newer sectors, and development ... The global biosensors space has seen the entry of ... market so far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ... Sullivan, Analysis of the Global Biosensors Market ...
(Date:7/31/2015)... , Kina, 31. juli 2015 Den ... bliver afholdt af BGI fra den 22. - 25. oktober ... Konferencen fejrer sin 10-års fødselsdag i år. Siden ... mest indflydelsesrige årlige møder på ,omik,-feltet, og er en ... ICG-10 fokuserer på nylige gennembrud og ...
(Date:7/31/2015)... 2015 La 10 th International Conference on ... BGI del 22 al 25 de octubre de 2015 en ... la conferencia celebra su décimo aniversario. Desde su inauguración en ... las reuniones anuales más influyentes del mundo en el campo ... entusiastas y mejores a nivel científico. ICG-10 ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... new method that could give a deeper insight into evolutional ... in EPJ Data Science . Paolo Masucci from the ... UK, and colleagues identified the segregation of genes that a ... exchange of genes, or gene flow, between populations of a ...
... WILMINGTON, N.C., Dec. 10, 2012 Chiltern International Limited ... Dr. Cedric Burg and James Gunter have joined Chiltern, ... clients, needs and to strengthen our Global Clinical Development ... to announce that Dr. Cedric Burg has been appointed ...
... means of controlling urban insect pests by using ultrasonic ... few of these devices have been demonstrated as being ... or ants. Despite the lack of evidence for the ... and new versions targeting bed bugs are readily available. ...
Cached Biology News:Tracking gene flow in marine plant evolution 2Chiltern Welcomes Cedric Burg And James Gunter 2
... GELase™ Agarose Gel-Digesting Preparation contains a ... for simple, quantitative recovery of intact DNA ... agarose gels following electrophoresis in TAE, TBE, ... be digested directly in the TAE, TBE, ...
Request Info...
... has established an expertise in the forefront ... solid support synthesis and synthesis in solution. ... Mass Spectrometry and analytical HPLC at no ... that meet the highest quality standard. , ...
... Thermo Labsystems' Wellwash AC ... twin-strip microplate washer available, and ... sensors for wash, waste and ... shaker and automatic rinsing and ...
Biology Products: